Takeda raises full-year net income forecast by 26%

The story

Takeda Pharmaceutical is reported to have revised its current fiscal year net profit forecast upward from the previous estimate. The revision is given as 26% in the headline, and the company's earnings outlook for the current fiscal year is said to have been raised.

The article contains no other specific earnings figures or detailed timing, and provides no additional information on the reasons for or impact of the revision.

At a glance

Target companyTakeda Pharmaceutical reportedly raised its current fiscal year net profit forecast by 26%

Reference information. Every claim resolves to something the story actually named.

Where this came from

We read each source in full and checked they agree on the core claim.

1/ 1 agree

All of them report the same thing.

KabutanNews

AgreesOpen

View the original filingThe timely-disclosure document itself

Reference information generated from public sources. It does not solicit or advise on investments. Prices are 15-minute delayed.